Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histone H2A type 2-B (H2AC21) is a core histone protein that, along with H2B, H3, and H4, forms the histone octamer around which DNA winds to create nucleosomes, the fundamental units of chromatin structure in eukaryotic nuclei[2][4]. H2A variants, including H2AC21, display significant sequence divergence in their terminal regions, which can influence nucleosome stability, DNA accessibility, and chromatin fiber formation[2]. These properties are essential for cellular processes including DNA replication, gene expression regulation, DNA repair, and higher-order chromatin dynamics[2][4]. Post-translational modifications of H2A (such as monoubiquitylation) can participate in DNA repair-induced chromatin remodeling[4]. While some histone variants (such as H2A.X) have a more direct role in genome stability and DNA repair, H2AC21 is primarily a component of the canonical histone pool in humans and is not itself a common drug target, receptor, or disease biomarker. Not a classic drug target or receptor; rather, H2AC21 is a protein component essential for fundamental chromatin structure and function[2][4]. Roles in health and disease are mostly indirect, via its influence on the epigenome. No drugs are known to directly or selectively target H2AC21. Not used as a biomarker in clinical practice.
Not applicable (no direct therapeutics or drugs established for H2AC21)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histone H2A type 2-B (H2AC21).